IDEXX Laboratories (IDXX) Competitors

IDEXX Laboratories (NASDAQ:IDXX) and Stryker (NYSE:SYK) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, community ranking and media sentiment.

Does the MarketBeat Community believe in IDXX or SYK?

Stryker received 397 more outperform votes than IDEXX Laboratories when rated by MarketBeat users. However, 71.73% of users gave IDEXX Laboratories an outperform vote while only 64.53% of users gave Stryker an outperform vote.

Company	Underperform	Outperform
IDEXX Laboratories	Outperform Votes 538 71.73%	Underperform Votes 212 28.27%
Stryker	Outperform Votes 935 64.53%	Underperform Votes 514 35.47%

Do analysts rate IDXX or SYK?

IDEXX Laboratories presently has a consensus price target of $523.75, indicating a potential upside of 11.48%. Stryker has a consensus price target of $424.56, indicating a potential upside of 13.04%. Given Stryker's higher probable upside, analysts plainly believe Stryker is more favorable than IDEXX Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.78
Stryker	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78

Does the media prefer IDXX or SYK?

In the previous week, IDEXX Laboratories had 3 more articles in the media than Stryker. MarketBeat recorded 34 mentions for IDEXX Laboratories and 31 mentions for Stryker. IDEXX Laboratories' average media sentiment score of 1.26 beat Stryker's score of 1.23 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	20 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Stryker	25 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals and insiders believe in IDXX or SYK?

87.8% of IDEXX Laboratories shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 1.0% of IDEXX Laboratories shares are held by company insiders. Comparatively, 5.9% of Stryker shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Which has more volatility and risk, IDXX or SYK?

IDEXX Laboratories has a beta of 1.5, indicating that its stock price is 50% more volatile than the S&P 500. Comparatively, Stryker has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500.

Which has preferable earnings and valuation, IDXX or SYK?

Stryker has higher revenue and earnings than IDEXX Laboratories. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$3.90B	9.77	$887.87M	$10.67	44.03
Stryker	$22.60B	6.34	$2.99B	$7.76	48.40

Is IDXX or SYK more profitable?

IDEXX Laboratories has a net margin of 22.78% compared to Stryker's net margin of 13.25%. IDEXX Laboratories' return on equity of 55.82% beat Stryker's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	22.78%	55.82%	26.48%
Stryker	13.25%	23.58%	11.37%

Summary

IDEXX Laboratories beats Stryker on 11 of the 18 factors compared between the two stocks.